Abstract: Embodiments of the present disclosure provide a solution for keyword determination. A method includes: presenting an interface comprising a plurality of information fields associated with an object; in response to detecting completion of input in a first information field among the plurality of information fields, determining at least one candidate keyword for the object based on first information input in the first information field, the first information comprising at least one of: text or visual information; and presenting the at least one candidate keyword for selection into at least one of the plurality of information fields. This solution allows efficient and timely keyword determination while the user is editing or modifying the object information.

Abstract: Provided herein is a technology for an Autonomous Vehicle Intelligent System (AVIS), which facilitates vehicle operations and control for autonomous driving. The AVIS and related methods provide vehicles with vehicle-specific information for a vehicle to perform driving tasks such as car following, lane changing, and route guidance. The AVIS comprises an onboard unit (OBU), wherein the OBU comprises a communication module communicating with one or more of other autonomous vehicles (AV), a roadside unit (RSU), a cloud platform, and a traffic control center/traffic control unit (TCC/TCU). The AVIS implements one or more of the following functions: sensing, prediction, decision-making, and vehicle control using onboard information and vehicle-specific information received from other AVs, the RSU, the cloud platform, and/or the TCC/TCU.

Abstract: The invention provides systems and methods for a computing power allocation system for autonomous driving (CPAS-AD), which is a component of an Intelligent Road Infrastructure System (IRIS). The CPAS-AD incorporates advanced computing capabilities that effectively allocate computational power for sensing, prediction, planning, decision-making, and control functions to enable end-to-end driving functions. In addition to the vehicle, the CPAS-AD can acquire additional computation resources from one or more of: (a) a roadside unit (RSU) network, (b) a cloud platform, (c) a traffic control center/traffic control unit (TCC/TCU), and (d) a traffic operations center (TOC). Additionally, tailored to different traffic scenarios, the CPAS-AD can allocate data and computation resources (including but not limited to CPU and GPU) for vehicle sensing, prediction, planning, decision-making, and control functions, thereby enabling safe and efficient autonomous driving.

Abstract: A radio frequency (RF) front-end circuit has a multi-way switch, an output terminal, and a shunt circuit. The multi-way switch has an input end, a plurality of output ends, and a control end. The input end is coupled to an antenna for receiving a radio frequency signal from the antenna. The control end is used to couple the input end to one of the output ends according to a switch control signal. The shunt circuit is coupled between the multi-way switch and the output terminal to provide one of shunt paths according to the switch control signal. The shunt paths correspond to different amounts of rejection to the radio frequency signal.

Abstract: This application relates to the field of communication technologies, and discloses a data transmission method, a program product, and an electronic device. The method includes: determining that a network transmission status satisfies a first condition; and reducing the first transmit power to second transmit power in response to that current first transmit power is greater than lower limit power of a first transmit power range corresponding to a current first transmission rate; or determining that the network transmission status does not satisfy the first condition; and adjusting network transmission parameters to enable the network transmission status to satisfy the first condition.

Abstract: The present invention belongs to the field of medical technology and specifically relates to an active ingredient group for treating constipation. An active ingredient group for treating constipation, characterized in that the active ingredient group includes rhein, hesperetin, albiflorin, and magnolol. The key target combination of constipation includes RXRA, CYP1A1, CYP1A2 and PLA2G4. The active ingredient group for treating constipation provided in this application can effectively prevent and treat constipation by regulating bile acid secretion, steroid hormone biosynthesis, glycerophospholipid metabolism, and linoleic acid metabolism by establishing strong combination between the active ingredient group and the key target combination of constipation. This application also discloses the biomarkers for the diagnosis and treatment of constipation.

Abstract: The invention provides systems and methods for a function-based computing power allocation system (FCPAS), which is a component of an Intelligent Road Infrastructure System (IRIS). The FCPAS incorporates advanced computing capabilities that effectively allocate computational power for prediction, planning, and decision making functions. Specifically, through the FCPAS, an AV can acquire additional computational resources for vehicle prediction, planning, and decision-making functions, thereby enabling safe and efficient autonomous driving. Additionally, tailored to different traffic scenarios, the FCPAS can allocate data and computational resources (including but not limited to CPU and GPU) for vehicle automation.

Abstract: Methods, systems, and computer-readable storage media for receiving, through a set of user interfaces (UIs), user input including job configuration information and deployment information for an application, providing a CI/CD job for the application with a CI/CD service using the job configuration information and the deployment information, and triggering, in response to a commit of changes to the application in a repository, automated build of the application, and in response, automatically: generating a development descriptor file at least partially based on the user input, providing an archive file including the development descriptor file, and processing, by the CI/CD job executed by the CI/CD service, the archive file to deploy the application within the target environment.

Abstract: Disclosed are an ultrasonic imaging method, an ultrasonic imaging system and a computer storage medium. The method includes: transmitting ultrasonic waves to a region of interest, including transmitting multiple pulses to the same target position (S110); receiving ultrasonic echoes to obtain an ultrasonic echo signal (S120); performing beam synthesis to obtain a beam-synthesized signal for each transmission (S130); performing autocorrelation calculation on the beam-synthesized signal for each transmission to obtain an autocorrelation function characterizing the blood flow signal for each transmission (S140); synthesizing the autocorrelation functions obtained after multiple transmissions to obtain a synthesized autocorrelation function (S150); and obtaining a color blood flow image based on the synthesized autocorrelation function (S160).

Abstract: A method for model predictive current control of a two-motor torque synchronization system, which belongs to the field of power electronics and motor control. The present disclosure takes an indirect matrix converter and a two-motor system which are coaxially and rigidly connected as a target, and takes two-motor torque synchronization performance and current tracking performance as main control objectives. A two-motor unified prediction model is established and a value function based on free components of error items is configured so as to solve the problems in which when model predictive current control is performed on a two-motor system, setting of a value function weighting coefficient needs to be performed manually, and consequently the setting process is complicated and an erroneous switch state combination is likely to be selected.

Abstract: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.

Abstract: Provided are a sound gathering device for voiceprint monitoring and a preparation method. The sound gathering device is a cone structure and includes a front end portion (1) and a rear end portion (2), the front end portion (1) is trumpet-shaped, an inner wall surface of the front end portion (1) is present a pattern array of a microstructure (3), and the microstructure (3) presenting the pattern array is formed through laser etching. A sound wave frequency monitored by the sound gathering device is 50 Hz˜10 kHz, and a sound wave enters the sound gathering device from an entrance of the front end portion (1), is reflected through the pattern array of the microstructure (3) on the inner wall surface of the front end portion (1), and is transmitted from an exit of the rear end portion (2), and a sound pressure of the exit of the rear end portion (2) is 4 times˜8 times a sound pressure of the entrance of the front end portion (1).

Abstract: Provided are an endovascular-stent-based electrode array, a method for manufacturing the same, and an electrical stimulation system. The endovascular-stent-based electrode array includes a stent woven from stent woven wires. The stent woven wires include at least one first metal woven wire, each respective first metal woven wire includes an insulated segment and a conductive segment axially arranged, the insulated segment is electrically insulated from other stent woven wires and a human tissue, and the conductive segment is configured to perform at least one of: delivering a stimulation pulse to a nerve surrounding the human tissue, and sensing an electrical signal from the nerve surrounding the human tissue. A proximal end of the respective first metal woven wire is configured to be electrically connected to an external device, and a distal terminal end of the respective first metal woven wire is electrically insulated from the human tissue.

Abstract: The present disclosure provides a virtual viewpoint synthesis method, including: pre-processing a depth image with zero parallax corresponding to an original image to obtain a processed depth image; generating virtual viewpoint images corresponding to a plurality of virtual viewpoints respectively according to the processed depth image and the original image; and filling holes in the virtual viewpoint image to generate a plurality of filled virtual viewpoint images. The present disclosure further provides an electronic apparatus and a computer-readable medium.

Abstract: The present invention relates to a process for producing succinic anhydride by maleic anhydride hydrogenation, comprising (1) feeding a maleic anhydride solution and a hydrogen raw material respectively to a first-stage hydrogenation reactor from an upper liquid-phase feed port and a top gas-phase feed port of the first-stage hydrogenation reactor for a first-stage hydrogenation reaction to obtain a first-stage hydrogenation product; (2) feeding the first-stage hydrogenation product to a second-stage hydrogenation reactor for a second-stage hydrogenation reaction to obtain a second-stage hydrogenation product, optionally, before entering the second-stage hydrogenation reactor, subjecting the first-stage hydrogenation product to a first-stage gas-liquid separation to obtain a first-stage gas phase and a first-stage liquid phase, and then feeding the first-stage gas phase and the first-stage liquid phase respectively from a top gas-phase feed port and an upper liquid-phase feed port of the second-stage hydrogen

Abstract: A device for cleaning a finished monocrystalline square rod may include a washer arranged on a side of the square rod for washing the square rod and a dryer arranged around the square rod for blow-drying the washed square rod.

Abstract: The present disclosure relates to a compound containing cycloalkyl or haloalkyl, and specifically discloses a compound represented by formula I?, a stereoisomer or a pharmaceutically acceptable salt thereof, a preparation method therefor, a pharmaceutical composition containing the compound, and a use thereof in treating tumors.

Abstract: The present disclosure provides a silicon bar rinsing device comprising: a rinsing portion, wherein the rinsing portion is a cavity having a upper opening and is configured to rinse the silicon bar; an adjusting portion disposed in the rinsing portion; a compressed air pipeline disposed on a side of the rinsing portion and communicated with the rinsing portion; a reuse water pipeline disposed on an other side of the rinsing portion opposite to the compressed air pipeline and communicated with the rinsing portion; and a control unit disposed on a upper end of the rinsing portion and configured to control turning on or off of the silicon bar rinsing device.

Abstract: The present disclosure provides a A driving method of a display panel, including: determining a target region and a non-target region in the display panel; dividing the target region into a plurality of target sub-regions, and dividing the non-target region into a plurality of non-target sub-regions, wherein an area of the target sub-region is less than that of the non-target sub-region; determining brightness compensation values of each target sub-region and each non-target sub-region according to a gray scale value of each pixel in an input image; determining a compensated brightness of each pixel unit in the display panel according to the gray scale value of each pixel in the input image, the brightness compensation values of each target sub-region and each non-target sub-region; and driving each pixel unit in the display panel to emit light according to the compensated brightness of each pixel unit in the display panel.

Abstract: The present invention provides compounds of Formula (I) or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.